# M&A DUE DILIGENCE EXECUTIVE SUMMARY TEMPLATE

**To:** Investment Committee
**From:** M&A Due Diligence Team
**Date:** [INSERT DATE]
**Recommendation:** [PROCEED WITH CAUTION - CONDITIONAL BUY / STRONG BUY / HOLD / SELL]

---

## INVESTMENT THESIS

[INSERT COMPANY NAME] represents a [unique/strategic/standard] M&A opportunity combining [key strengths] with [significant/acceptable/minimal] execution risks. The company has demonstrated [describe growth and performance] but faces [describe key challenges/questions].

## KEY METRICS

| Metric | Value | Assessment |
|--------|-------|------------|
| **Current Market Cap** | [INSERT VALUE] | [Assessment] |
| **DCF Valuation Range** | [INSERT RANGE] | [Assessment] |
| **Base Case DCF** | [INSERT VALUE] | [Assessment] |
| **5-Year Revenue CAGR** | [INSERT VALUE] | [Assessment] |
| **Gross Margin** | [INSERT VALUE] | [Assessment] |
| **Financial Health Score** | [INSERT VALUE] | [Assessment] |
| **Overall Confidence** | [INSERT VALUE] | [Assessment] |

## STRENGTHS

✅ **[STRENGTH 1]**
- [Detailed description]
- [Supporting metrics]
- [Strategic importance]

✅ **[STRENGTH 2]**
- [Detailed description]
- [Supporting metrics]
- [Strategic importance]

✅ **[STRENGTH 3]**
- [Detailed description]
- [Supporting metrics]
- [Strategic importance]

✅ **[STRENGTH 4]**
- [Detailed description]
- [Supporting metrics]
- [Strategic importance]

## CRITICAL RISKS

❌ **[RISK 1]**
- [Risk description]
- [Impact assessment]
- [Probability/Likelihood]

❌ **[RISK 2]**
- [Risk description]
- [Impact assessment]
- [Probability/Likelihood]

❌ **[RISK 3]**
- [Risk description]
- [Impact assessment]
- [Probability/Likelihood]

❌ **[RISK 4]**
- [Risk description]
- [Impact assessment]
- [Probability/Likelihood]

## STRATEGIC RATIONALE

[INSERT COMPANY NAME]'s [key assets/platform/market position] provide strategic value beyond pure financial metrics:

- **[Strategic Value 1]:** [Description and importance]
- **[Strategic Value 2]:** [Description and importance]
- **[Strategic Value 3]:** [Description and importance]
- **[Strategic Value 4]:** [Description and importance]

## RECOMMENDED DEAL STRUCTURE

### Primary Structure: [Earn-Out Transaction / Stock-for-Stock / All-Cash]

**[Upfront Consideration]:** [INSERT VALUE] ([DCF Base Case/Strategic Value])
**[Earn-Out Component]:** [INSERT STRUCTURE]

**Milestone Structure:**
- **Year 1:** [INSERT PAYMENT] ([INSERT METRICS])
- **Year 2:** [INSERT PAYMENT] ([INSERT METRICS])
- **Year 3:** [INSERT PAYMENT] ([INSERT METRICS])

### Alternative: [Stock-for-Stock / All-Cash / Mixed Structure]

**[Exchange Ratio]:** [INSERT RATIO] (based on [INSERT METHODOLOGY])
**[Collar Protection]:** [INSERT RANGE]
**[Cash Component]:** [INSERT PERCENTAGE] of total consideration

## RISK MITIGATION STRATEGIES

1. **[Strategy 1]:** [Description and implementation]
2. **[Strategy 2]:** [Description and implementation]
3. **[Strategy 3]:** [Description and implementation]
4. **[Strategy 4]:** [Description and implementation]

## NEXT STEPS

### Immediate Actions (Next 30 days)
- [Action 1 with timeline]
- [Action 2 with timeline]
- [Action 3 with timeline]
- [Action 4 with timeline]

### Phase 1 Due Diligence (30-60 days)
- [Action 1 with timeline]
- [Action 2 with timeline]
- [Action 3 with timeline]
- [Action 4 with timeline]

### Phase 2 Integration Planning (60-90 days)
- [Action 1 with timeline]
- [Action 2 with timeline]
- [Action 3 with timeline]
- [Action 4 with timeline]

## SUCCESS METRICS

1. **[Metric 1]:** [Target and measurement methodology]
2. **[Metric 2]:** [Target and measurement methodology]
3. **[Metric 3]:** [Target and measurement methodology]
4. **[Metric 4]:** [Target and measurement methodology]
5. **[Metric 5]:** [Target and measurement methodology]

**[Risk-Adjusted Recommendation]:** [Final recommendation with key caveats]

---

**Prepared by:** M&A Due Diligence Team
**Contact:** due.diligence@aimadds.com
**Classification:** CONFIDENTIAL

**Template Version:** 1.0
**Last Updated:** [INSERT DATE]
**Applicable To:** All M&A Transactions
